Julia P Dunn1,2, Naji N Abumrad3, Robert M Kessler4, Bruce W Patterson5, Rui Li4, Pamela Marks-Shulman3, Robyn A Tamboli2,3. 1. Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. 2. Veterans Administration St. Louis Health Care System, St. Louis, Missouri, USA. 3. Department of Surgery, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. 4. Department of Radiology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. 5. Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
Abstract
OBJECTIVE: It has been previously reported that early after Roux-en-Y-gastric bypass, dopamine (DA) type 2 and 3 receptor (D2/3R) binding potential (BPND ) was decreased from preoperative levels. The current study aimed to determine whether calorie restriction without weight loss modifies D2/3R BPND and whether such changes are explained by neuroendocrine regulation. METHODS: Fifteen females with obesity (BMI = 39 ± 6 kg/m2 ) were studied before and after ∼10 days of a very-low-calorie-diet (VLCD). Outcome measures included fasting insulin, leptin, acyl ghrelin, and glucose, and insulin sensitivity and disposition index were estimated using the oral-minimal model (OMM) method. Participants underwent positron emission tomography scanning with the displaceable radioligand [18 F]fallypride to estimate available regional D2/3R levels. Regions of interest included the caudate, putamen, ventral striatum, hypothalamus, and substantia nigra (SN). RESULTS: With the VLCD, weight decreased slightly (-3 kg). Insulin, glucose, and leptin decreased significantly, but there was no change in acyl ghrelin or measures from OMM. SN D2/3R BPND decreased significantly, with trends toward decreased levels in the remaining regions. The decrease in leptin concentration strongly predicted the change in D2/3R BPND in all regions (all P ≤ 0.004). CONCLUSIONS: In obesity, reductions in regional D2/3R availability after VLCD are suggestive of increased endogenous DA competing with the radioligand. Changes in regional D2/3R availability were associated with decreases in leptin concentrations that occurred before clinically significant weight loss.
OBJECTIVE: It has been previously reported that early after Roux-en-Y-gastric bypass, dopamine (DA) type 2 and 3 receptor (D2/3R) binding potential (BPND ) was decreased from preoperative levels. The current study aimed to determine whether calorie restriction without weight loss modifies D2/3R BPND and whether such changes are explained by neuroendocrine regulation. METHODS: Fifteen females with obesity (BMI = 39 ± 6 kg/m2 ) were studied before and after ∼10 days of a very-low-calorie-diet (VLCD). Outcome measures included fasting insulin, leptin, acyl ghrelin, and glucose, and insulin sensitivity and disposition index were estimated using the oral-minimal model (OMM) method. Participants underwent positron emission tomography scanning with the displaceable radioligand [18 F]fallypride to estimate available regional D2/3R levels. Regions of interest included the caudate, putamen, ventral striatum, hypothalamus, and substantia nigra (SN). RESULTS: With the VLCD, weight decreased slightly (-3 kg). Insulin, glucose, and leptin decreased significantly, but there was no change in acyl ghrelin or measures from OMM. SN D2/3R BPND decreased significantly, with trends toward decreased levels in the remaining regions. The decrease in leptin concentration strongly predicted the change in D2/3R BPND in all regions (all P ≤ 0.004). CONCLUSIONS: In obesity, reductions in regional D2/3R availability after VLCD are suggestive of increased endogenous DA competing with the radioligand. Changes in regional D2/3R availability were associated with decreases in leptin concentrations that occurred before clinically significant weight loss.
Authors: Paulette B Goforth; Gina M Leinninger; Christa M Patterson; Leslie S Satin; Martin G Myers Journal: J Neurosci Date: 2014-08-20 Impact factor: 6.167
Authors: Julia P Dunn; Ronald L Cowan; Nora D Volkow; Irene D Feurer; Rui Li; D Brandon Williams; Robert M Kessler; Naji N Abumrad Journal: Brain Res Date: 2010-03-31 Impact factor: 3.252
Authors: Luis A Tellez; Wenfei Han; Xiaobing Zhang; Tatiana L Ferreira; Isaac O Perez; Sara J Shammah-Lagnado; Anthony N van den Pol; Ivan E de Araujo Journal: Nat Neurosci Date: 2016-01-25 Impact factor: 24.884
Authors: Michael F Salvatore; Ella A Kasanga; D Parker Kelley; Katy E Venable; Tamara R McInnis; Mark A Cantu; Jennifer Terrebonne; Kathryn Lanza; Samantha M Meadows; Ashley Centner; Christopher Bishop; Donald K Ingram Journal: Geroscience Date: 2022-05-30 Impact factor: 7.713
Authors: Debra K M Tacad; Ashley P Tovar; Christine E Richardson; William F Horn; Giri P Krishnan; Nancy L Keim; Sridevi Krishnan Journal: Adv Nutr Date: 2022-06-01 Impact factor: 11.567